Radionuclide Imaging (PET) Publications

PET Image

 “Use of Fc-engineered antibodies as clearing agents to increase contrast during PET”, R. Swiercz, S. Chiguru, A. Tahmasbi, S. M. Ramezani, G. Hao,  D. K. Challa, M. A. Lewis, P. V. Kulkarni, X. Sun, R. J. Ober, R. P. Mason & E. S. Ward, J. Nucl. Medpublished ahead of print May 27, 2014 (10.2967/jnumed.113.136481).

Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine. Jennewein M., Lewis M.A., Zhao D., Tsyganov E., Slavine N., He J., Watkins L., Kodibagkar V.D., O'Kelly S., Kulkarni P., Antich P.P., Hermanne A., Rösch F., Mason R.P., Thorpe P.E. Clin. Cancer Res. 2008 Mar 14 5 1377-85.

“Molecular imaging in prostate cancer”, J. A. Karam, R. P. Mason, K. S. Koeneman, P. P. Antich, E. A. Benaim, J.T. Hsieh, J. Cell. Biochem. 90, 473-83 (2003)

Krohn KA, Link JM, and Mason RP: Molecular Imaging of Hypoxia, J. Nucl. Med., 2008; 49:129S-148S. PMID: 18523070

“Multimodality imaging of hypoxia in preclinical settings” R. P. Mason, D. Zhao, J. Pacheco-Torres, W. Cui, V. D. Kodibagkar, P. K. Gulaka, G. Hao, P. Thorpe, E. W. Hahn and P. Peschke, QJ Nucl. Med Mol Imaging 54(3):259-80 2010 [PMCID: PMC3044928; NIHMSID: NIHMS261584